New Frontiers in Ophthalmology

Chaired by Professor Billy Power of the Royal Victoria Eye and Ear Hospital, Dublin, our online meeting this year provided a focus on Refractive Surgery.

With internationally renowned expert speakers joining us from Boston Mass Eye and Ear Hospital and The New York Eye and Ear Infirmary, an exciting and topical meeting was assured.

Speakers

James Chodosh MD, MPH

Associate Director, Cornea & Refractive Surgery

Associate Chief of Ophthalmology Education Massachusetts Eye and Ear

Edith Ives Cogan Professor of Ophthalmology, Harvard Medical School

James Chodosh, MD, MPH is the Edith Ives Cogan Professor of Ophthalmology, Harvard Medical School (HMS).  He serves as Vice Chair for Education, Director of Diversity and Inclusion, Associate Director of the Cornea and Refractive Surgery Service, Associate Director of the Infectious Disease Institute, Director of Boston Keratoprosthesis, and Director of the Ocular Burn Service at Mass. Eye and Ear, an HMS affiliate.  He is also a member of the HMS PhD Program in Virology.  He completed his residency in Ophthalmology at Baylor College of Medicine, clinical fellowship in Corneal Diseases at the Bascom Palmer Eye Institute, postdoctoral research fellowship in Virology & Molecular Biology and Infectious Diseases at St. Jude Children’s Research Hospital, and Masters of Public Health degree at the University of Oklahoma.  Heis a recipient of the Alcon Research Institute Award and four awards for Research to Prevent Blindness.  He served as Chair of the Anterior Eye Disease NIH Study Section, on the National Advisory Eye Council for the NIH, and is currently Chair of the FDA Dermatologic and Ophthalmic Drugs Advisory Committee.  Dr Chodosh has published over 350 peer reviewed papers and book chapters and was co-Editor-in-Chief of the British Journal of Ophthalmology.  He has personally trained over 60 clinical cornea fellows.  He is internationally known and respected for his work on viral genomics and pathogenesis, and his basic research program has been continuously funded by the NIH since 1996. He is the senior author for the Americal Academy of Ophthalmology web pages on COVID-19, which have garnered over 1.5 million views.  His primary clinical interests include infectious eye disease, ocular chemical injury, Stevens Johnson syndrome, and the restoration of seemingly hopeless cases of corneal blindness with the Boston keratoprosthesis.

Angie E. Wen, MD

Assistant Professor of Ophthalmology, Icahn School of Medicine at Mount Sinai

Cornea External Disease and Refractive Surgery, Comprehensive Ophthalmology, Cornea Fellowship Program Director, New York Eye and Ear Infirmary of Mount Sinai

Angie E. Wen MD is a board-certified ophthalmologist specializing in the latest advanced corneal transplantation and cataract surgery techniques.  She also performs LASIK and other refractive surgery, as well as anterior segment and ocular surface reconstruction.  Dr Wen is a graduate of the combined BA/MD program at Northwestern University and completed her residency training in Ophthalmology at the Kresge Eye Institute in Detroit, Michigan.  She went on to pursue Cornea fellowship training at the Harkness Eye Institute at Columbia University in New York City.

Dr Wen is a member of the full-time Ophthalmology Faculty Practice at the New York Eye and Ear Infirmary of Mount Sinai.  She has trained many generations of future eye surgeons, serving as the current Cornea Fellowship Director at NYEE of MS, as well as a Resident Clinical Instructor at Columbia University and Assistant Professor of Ophthalmology at SUNY Downstate in the past.  Dr Wen’s research interests include ocular surface disease, surgical techniques and clinical outcomes.  She has authored multiple articles and book chapters and sits on the Medical Advisory Board of the Eye Bank of New York, as well as serves a content writer and examiner for the Americal Board of Ophthalmology.  She is a member of the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery, among others.

Richard Rosen, MD, FACS, FASRS, CRA

Professor and Vice Chairman, Surgeon Director, Chief of Retinal Services, Director of Research, New York Eye and Ear Infirmary

Dr Richard Rosen joined the New York Eye and Ear Infirmary of Mount Sinai (NYEE) in July 1986, as an Ophthalmology resident.  He had previous training as a professional photographer and ophthalmic photographer for Dr Morton Rosenthal and is a long-time member of the Ophthalmic Photographers Society achieving Certified Retinal Angiographer status.  During his time at NYEE, Dr Rosen has been mainstay of the teaching program and has been honoured by graduating residents on numerous occasions for his devotion and dedication to teaching and patient care.  During his fellowship Dr Rosen served as Director of Medical Student Education and went on to serve as Program Director for the Department of Ophthalmology from 1992-2002.  In 2002 he was named Vice-Chair of the Department and Director of Research and Surgeon-Director, Ophthalmology.  Dr Rosen has maintained a wide interest in vision and has been involved in basic science, translational and clinical projects.  He has numerous grants especially in Retinal Imaging where he has achieved a well-deserved international reputation.  He has authored over 100 peer-reviewed publications, numerous abstracts and lectures extensively locally, nationally and internationally.

Programme

GMT 6.00pm – 6.05pm

Chair, Professor Billy Power, Royal Victoria Eye & Ear Hospital Welcome and Introduction

GMT 6.05pm – 6.35pm

Dr James Chodosh, Associate Director, Cornea & Refractive Surgery, Massachusetts Eye and Ear Hospital ‘Boston Keratoprosthesis:  Present and Future’

GMT 6.35pm – 6.45pm

Discussion

GMT 6.45pm – 7.05pm

Dr. Angie E Wen, Assistant Professor of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai ‘Multifocal IOLs:  An Array of Options’

GMT 7.05pm – 7.25pm

Dr. Richard Rosen, Vice Chairman & Surgeon Director, New York Eye and Ear Infirmary of Mount Sinai ‘Advancing Ophthalmic Surgery – The Promise of Robotics’

GMT 7.25pm – 7.55pm

Panel & Audience Virtual Roundtable
Dr. Angie E Wen. Dr. Richard Rosen
Professor Billy Power
Moderator: Professor Conor Murphy, Royal Victoria Eye & Ear Hospital

GMT 7.55pm

Chair, Professor Billy Power, Closing Remarks

CME awarded for this meeting

This meeting was kindly sponsored by Novartis

VIII New Frontiers in Ophthalmology Virtual Meeting 2020

‘Fluid vs. Function in the Treatment of Wet AMD’

Thursday 8th October

2020 was a challenging year for all, and we were delighted to be able to bring this key educational event online, connect with our colleagues, and continue to provide a forum for learning and knowledge sharing in Ophthalmology.

This year’s theme ‘Fluid vs. Function in the Treatment of Wet AMD’ provides to be an opportunity to come together and discuss this important topic with our speakers;

• Professor Matthew Campbell, Smurfit Institute for Genetics, Trinity College Dublin, (Biography)

• Professor Robin Hamilton, Moorfields Eye Hospital, London, (Biography)
• Ms. Andrea Ryan, Royal Victoria Eye and Ear Hospital, Dublin

Chaired by Mr. Mark Cahill, Royal Victoria Eye and Ear Hospital, Dublin

Programme

18.00 – 18.05 Chair, Mr Mark Cahill, Royal Victoria Eye & Ear Hospital

Welcome and introduction

18.05 – 18.35 Prof Matthew Campbell, Smurfit Institute of Genetics, Trinity College Dublin

The Dynamic Blood Retina Barrier in AMD

19.05 – 19.35 Prof Matthew Campbell, Mr Robin Hamilton, Mr Mark Cahill, Moderator: Ms Andrea Ryan, Royal Victoria Eye & Ear Hospital

‘Fluid vs Function’ Speaker & Audience Virtual Roundtable

19.35 – 19.45 Chair, Mr Mark Cahill

Closing remarks

This meeting has been awarded 2 External Points & 0.5 Internal CME Points by the Irish College of Ophthalmology

1 CPD credit is equivalent to 1 hour of educational activity

This meeting was supported by Novartis

VII New Frontiers in Ophthalmology Meeting

‘Paedriatric Ophthalmology & Strabismus’

9.30 – 13.00, Thursday 20th June 2019, Education & Conference Centre, Royal Victoria Eye & Ear Hospital

Speakers at the 2019 meeting:

Mr. Joe Abbot, Birmingham Women’s and Children’s Hospital

Ms. Arundhati Dev Borman, Great Ormond Street Hospital

Mr. Stephen Farrell, Temple Street Children’s Hospital & MMUH

Mr. Ian Flitcroft, Temple Street Children’s Hospital & MMUH

Mr. Ian Marsh, University Hospital Aintree

Programme

08.30 – 09.30 Registration

09.30 – 09.35 Chair, Mr Edward Loane, Royal Victoria Eye & Ear Hospital

Welcome and Introduction

09.35 – 10.05 Mr. Ian Flitcroft, Temple Street Children’s Hospital & MMUH

Active myopia management and the paediatric ophthalmologist

10.05 – 10.10 Discussion & Questions

10.10 – 10.40 Mr. Stephen Farrell, Temple Street Children’s Hospital & MMUH

Childhood Cataract

10.40 – 10.45 Discussion & Questions

10.45 – 11.15 Ms. Arundhati Dev Borman, Great Ormond Street Hospital

Paediatric Demyelinating Optic Neuritis

11.15 – 11.20 Discussion & Questions

11.20 – 11.50 Break

11.50 – 12.20 Mr. Joe Abbott, Birmingham Women’s and Children’s Hospital

New developments in Retinoblastoma

12.20 – 12.25 Discussion & Questions

12.25 – 12.55 Mr. Ian Marsh, University Hospital Aintree

The changes in Management in Neurological Strabismus over the last 40 years

12.55 – 13.00 Discussion & Questions

13.00 – 13.05 Chair, Mr Edward Loane, Royal Victoria Eye & Ear Hospital

Closing Remarks

13.05 – 14.00 Lunch

14.00 – 17.00 Eithne Walls Research Meeting 2019

This meeting is awarded 4 CPD credits from the Irish College of Ophthalmology

The meeting is supported by Novartis

Ocular Inflammation

The 2018 New Frontiers in Ophthalmology took place on Thursday 7th June.
Always an important event in the calendar year, this year’s meeting again played host to expert speakers and international colleagues, focusing on advances in Ocular Inflammation

Speakers included

• Dr John Fitzsimons, Our Lady of Lourdes Hospital, Drogheda
• Mr Barry Quill, Royal Victoria Eye & Ear Hospital
• Dr Monica Berry, University of Bristol
• Mr Athanasios Vardarinos, Consultant Ophthalmic Surgeon
• Prof Elizabeth Vandenberghe, St James’s Hospital
• Professor Friedrich Kruse, University of Erlangen, Germany

Programme

8.30 – 8.55 Registration – Tea & Coffee

8.55 – 9.00 Welcome and Introduction by Chair Professor Conor Murphy

9.00 – 9.25 Dr John Fitzsimons, Our Lady of Lourdes Hospital, Drogheda

‘Advances in the Diagnosis and Management of Allergy’

9.25 – 9.30 Questions

9.30 – 9.55 Mr. Barry Quill, Royal Victoria Eye & Ear Hospital, Dublin

‘Update on Ocular Allergy’

9.55 – 10.00 Questions

10.00 – 10.25 Dr Monica Berry, University of Bristol

‘Molecular chat: mucins, sugars and cells’

10.25 – 10.30 Questions

10.30 – 10.55 Mr Athanasios Vardarinos, Consultant Ophthalmic Surgeon
‘Evidence on treat and extend Ranibizumab continues to build. Review of the RIVAL interim results and real-world outcomes.

Questions

10.55 – 11.20 Tea/Coffee Break

11.20 – 11.45 Professor Elizabeth Vandenberghe, St. James’s Hospital, Dublin

‘The challenge of managing ocular Graft versus Host disease post stem cell transplantation’

11.45 – 11.50 Questions

11.50 – 12.45 Professor Friedrich Kruse, University of Erlangen, Germany

“New frontiers in ocular surface disorders”

12.45 – 13.00 Questions

13.00 – 14.00 Break for Lunch

The meeting is kindly sponsored by Novartis

• Professor Susan Kennedy, Consultant Pathologist, St. Vincent’s University Hospital
• Dr. Fiona Roberts, Consultant Pathologist Glasgow University Hospital
• Dr. Arun Singh, Professor of Ophthalmology and Director, Cole Eye Institute Cleveland Clinic, Ohio
• Professor Heinrich Heimann, Consultant Ophthalmic Surgeon and Ocular Oncologist, Royal Liverpool University Hospital
• Professor Giuseppe Gullo, Consultant Medical Oncologist, St. Vincent’s University Hospital
• Professor John Crown, Consultant Medical Oncologist, St. Vincent’s University Hospital

Programme

8.30 – 8.55 Registration – tea and coffee

8.55 – 9.00 Welcome and Introduction by Chair Mr. Noel Horgan

9.00 – 9.15 Professor Susan Kennedy

‘The Enigma of Uveal Melanoma – Part 1’

9.15 – 9.30 Dr Fiona Roberts

‘The Enigma of Uveal Melanoma – Part 2’

9.30 – 9.40 Questions

9.40 – 9.55 Dr Arun Singh

‘Diagnosis of Uveal Melanoma – Pearls and Pitfalls’

9.55 – 10.05 Questions

10.05 – 10.20 Professor Heinrich Heimann

‘Treatment Choices in Uveal Melanoma’

10.20 – 10.30 Questions

10.30 – 11.00 Tea & coffee break

11.00 – 11.15 Dr Arun Singh

‘Genetics of Uveal Melanoma: Recent Advances in our Understanding’

11.15 – 11.25 Questions

11.25 – 11.40 Professor Heinrich Heimann

‘Fine Needle Biopsy in Uveal Melanoma, Pros and Cons’

11.40 -11.50 Questions

11.50 – 12.05 Mr Adrian Skelly (Novartis)

“A Snapshot of Value of Evidence in the Real-World (VERO)”

12.05 – 12.10 Questions

12.10 – 12.25 Professor Giuseppe Gullo

‘Survival in Uveal Melanoma: An Irish Patient Cohort’

12.25 – 12.35 Questions

12.35 – 12.50 Professor John Crown

‘Systemic Treatment for Uveal melanoma in the 21^st Century’

12.50 – 1.00 Questions

1.00 – 2.00 Break for Lunch

The meeting is supported by Novartis

• Dr Paul Kenna, Director of Research, Royal Victoria Eye & Ear Research Foundation
• Dr Sinead Connolly, Clinical Educator and Research Fellow, Royal College of Surgeons in Ireland
• Dr James Warburton, Novartis
• Dr Sarah Doyle, Assistant Professor in Immunology, Trinity College, Dublin

Programme

09.00 – 9.30 Registration/ tea and coffee

09.30 – 9.35 Welcome and introduction by Chair

09.35 – 10.10 Dr Sinead Connolly, Clinical Educator and Research Fellow, Royal College of Surgeons in Ireland

“Small Molecules with Big Potential – Nanoparticle Approaches in Ophthalmology”

10.10 – 10.45 Dr James Warburton, Novartis

Update on Novartis Ophthalmology Pipeline

10.45 – 11.00 Discussion

11.00 – 11.35 Tea & coffee break

11.35 – 12.10 Dr Paul Kenna, Director of Research, Royal Victoria Eye & Ear Research Foundation

“Inherited Retinal Degenerations – From Cause to ? Cure”

12.10 – 12.45 Dr Sarah Doyle, Assistant Professor in Immunology, Trinity College, Dublin

“The Potential of Immunotherapy for the Treatment of Neovascular AMD”

12.45 – 1.00 Discussion and close of meeting by Chair

1.00 – 2.00 Lunch

The meeting is supported by Novartis

Glaucoma Study Day

The meeting was chaired by Ms Aoife Doyle (Royal Victoria Eye & Ear Hospital).

Speakers included

• Prof Anthony J.W King (Nottingham University Hospital)
• Mr Jeremy O’Connor (Royal Victoria Eye & Ear Hospital)
• Yvonne Delaney (Bons Secour Hospital)
• Prof Colm O’Brien (Mater Misericordiae University Hospital)
• Ms Carol Hoang (Novartis Global Brand Medical Director)
• Prof Anthony King, Consultant Ophthalmic Surgeon, Honorary Clinical Professor of Ophthalmology, Nottingham University Hospital Surgery as initial intervention for advanced glaucoma
• Mr Jeremy O’Connor, Consultant Ophthalmic Surgeon, Royal Victoria Eye & Ear Hospital MIGS

Diabetic Retinopathy.

The New Frontiers in Ophthalmology Meeting was held on Thursday 12th June 2014 in the Education and Conference Centre of the Royal Victoria Eye & Ear Hospital.

Speakers included:

• Lloyd Paul Aiello (Harvard University)
• Mr Mark Cahill (Royal Victoria Eye & Ear Hospital)
• Dr Reinhold Medina (Queens University Belfast)
• Mr David Keegan (Mater Misericordiae University Hospital & Mater Private Hospital))
• Mr Rob Acheson (Mater Private Hospital))

The meeting was sponsored by Novartis. The meeting had a excellent turnout and we received very positive feedback. We would like to thank the speakers Mr Mark Cahill (Chair), Prof Lloyd Paul Aiello, Dr Reinhold Medina, Mr David Keegan and Mr Rob Acheson and in particular Novartis for making the meeting such a great success.

Lloyd Paul Aiello, MD, PhD, Professor of Ophthalmology, Harvard University

Journey to the Edge of the Retina / Journey through the Depths of the Retina

Mark Cahill, Clinical Lead, Global Vision, Royal Victoria Eye and Ear Hospital

Diabetic Retina Screen Photography and Grading: Why, Where and How (it’s done)

Reinhold Medina, M.D. Ph.D. Centre for Experimental Medicine, Dentistry & Biomedical Science, Queen’s University Belfast

Potential Uses for Endothelial Progenitors in Diabetic Retinopathy

David Keegan, PhD FRCOphth FRCSI(Oph) National Clinical Lead for Diabetic Retinopathy

Transition to a National Diabetic Retinopathy Screening and Treatment Programme

Robert Acheson, Clinical Lead, Mater Misericordiae University Hospital & Mater Private Hospital

Diabetic Retina Screen – Arbitration and Gatekeeping

Corneal Stem Cell and Tissue Engineering.

The New Frontiers in Ophthalmology Meeting took place on Thursday 27th June 2013 in the Education & Conference Centre at the Royal Victoria Eye & Ear Hospital.

The morning of the meeting was devoted to a symposium on corneal stem cell and tissue engineering. The use of cell-based therapies in the management of ocular surface and corneal disorders is a new and rapidly evolving field with many potential disease applications. In this symposium the advances in the development of such therapies to restore the epithelial and endothelial corneal surfaces and the potential to transfer of these developments to the clinical setting were discussed.

Speakers included:

• Prof Conor Murphy (Royal Victoria Eye and Ear Hospital)
• Mr Billy Power (Royal Victoria Eye and Ear Hospital)
• Dr Clair Gallagher (National Institute of Cellular Biotechnology, Dublin City University)
• Dr Finbarr O’Sullivan (National Institute of Cellular Biotechnology, Dublin City University)
• Prof Fergal O’Brien (Tissue Engineering Research Group, Royal College of Surgeons in Ireland)
• Dr Andrew Cameron (Tissue Engineering Research Group, Royal College of Surgeons in Ireland)
• Dr Kevin Kavanagh (NUI Maynooth)
• Sinead Masterson (Irish Medicines Board)

PROGRAMME

09.00 – 9.20 Registration/ tea and coffee

09.20 – 9.30 Welcome and introduction by Chair

Professor Conor Murphy, Professor of Ophthalmology, Royal Victoria Eye and Ear Hospital and Royal College of Surgeons in Ireland

Tissue engineering and the ocular surface

09.30 – 09.50 Mr Billy Power, Consultant Ophthalmic Surgeon, Royal Victoria Eye and Ear Hospital

Clinical indications for ocular surface reconstruction

09.50 – 10.10 Dr Kevin Kavanagh, Senior Lecturer, Department of Biology, NUI Maynooth

Analysis of the role of demodex-associated bacterial antigens in inducing corneal damage in ocular rosacea

10.10 – 10.30 Dr Finbarr O’Sullivan, Senior Scientist, National Institute of Cellular Biotechnology, Dublin City University

Repairing the window of the eye – tissue Engineering approaches to repairing corneal epithelial damage

10.30 – 10.50 Ms Sinead Masterson, Irish Medicines Board

Regulatory issues around the use of advanced therapies

10.50 – 11.00 Discussion

11.00 – 11.30 Tea and Coffee

Tissue engineering and the corneal stroma and endothelium

11.30 – 11.50 Professor Conor Murphy, Professor of Ophthalmology, RVEEH and RCSI

Clinical indications for treating corneal stromal and endothelial diseases with tissue engineering approaches

11.50 – 12.10 Professor Fergal O’Brien, Tissue Engineering Research Group, RCSI

Principles of tissue engineering and the use of collagen-based biomaterials in regenerative medicine

12.10 – 12.30 Dr Andrew Cameron, Post-doctoral Fellow, Tissue Engineering Research Group, RCSI

Towards the design of tissue engineered constructs for corneal regeneration

12.30 – 12.50 Dr Clair Gallagher, Post-doctoral Fellow, National Institute of Cellular Biotechnology, DCU

Tissue engineered corneal endothelium – exploiting the culture quirk

12.50 – 1.00 Discussion and close of meeting

1.00 – 2.00 Lunch

The afternoon was devoted to the Eithne Walls Research Meeting, at which NCHDs presented their latest research in competition for the Eithne Walls Medal and the Research Foundation Clinical Prize.

The meeting was well attended and supported by an unrestricted educational grant from Novartis.